Related Experiment Video
Updated: Apr 7, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Vaginal mucosal melanoma recurrence with intracardiac metastasis treated with immunotherapy
Janvi Singh1, Daniel Chen2, Melvin Chin2
1Chris O'Brien Lifehouse, Sydney, Australia.
Background:
Vaginal mucosal melanoma (VMM) is highly malignant tumour with limited cases reported worldwide. There are no guidelines in place to inform best therapy; instead, management is guided by previous studies and outcomes. There have been no reported cases of vaginal mucosal melanoma metastasizing to the heart.
Case Presentation:
This case follows 54-year-old, otherwise well woman with VMM metastasizing to the heart. It outlines diagnosis, multi-specialty input, chosen treatments and progress of recovery and successful disease control.
Conclusion:
Primary surgical resection and adjuvant immunotherapy were best indicated and depicted best survival outcomes for this case. Multidisciplinary expert care is essential in clinical decision making. Immunotherapy significant improved survival, and side effects were able to be managed with good response.
Related Concept Videos
Tumor Immunotherapy
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Treatment Resistent Cancers
Treatment Resistant Cancers

